Opthamology @Point of Care Podcasts

S1E5 - Ophthalmology Morning Commute : Optimizing Second-Generation Anti-VEGF Agents for nAMD

25 min · 7. Juli 2026
Episode S1E5 - Ophthalmology Morning Commute : Optimizing Second-Generation Anti-VEGF Agents for nAMD Cover

Beschreibung

Are you ready to rethink your neovascular age-related macular degeneration (nAMD) management strategies? New agents and evolving indications are rapidly reshaping the treatment landscape for nAMD. Join Dr. Diana Do and Dr. Deepak Sambhara for a discussion of clinical trial data and real-world evidence supporting the use of second-generation anti-vascular endothelial growth factor therapies in patients with nAMD. Visit Optimizing Second-Generation Anti-VEGF Agents for nAMD [https://suitehome.atpointofcare.com/library/2707.01/page/0?subdomain=dr\&time=1336000\&pre=skip\&utm_source=podcast] to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast [https://pinecast.com].

Kommentare

0

Sei die erste Person, die kommentiert

Melde dich jetzt an und werde Teil der Opthamology @Point of Care Podcasts-Community!

Loslegen

2 Monate für 1 €

Dann 4,99 € / Monat · Jederzeit kündbar

  • Podcasts nur bei Podimo
  • 20 Stunden Hörbücher / Monat
  • Alle kostenlosen Podcasts

Alle Folgen

8 Folgen

Episode S1E5 - Ophthalmology Morning Commute : Optimizing Second-Generation Anti-VEGF Agents for nAMD Cover

S1E5 - Ophthalmology Morning Commute : Optimizing Second-Generation Anti-VEGF Agents for nAMD

Are you ready to rethink your neovascular age-related macular degeneration (nAMD) management strategies? New agents and evolving indications are rapidly reshaping the treatment landscape for nAMD. Join Dr. Diana Do and Dr. Deepak Sambhara for a discussion of clinical trial data and real-world evidence supporting the use of second-generation anti-vascular endothelial growth factor therapies in patients with nAMD. Visit Optimizing Second-Generation Anti-VEGF Agents for nAMD [https://suitehome.atpointofcare.com/library/2707.01/page/0?subdomain=dr\&time=1336000\&pre=skip\&utm_source=podcast] to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast [https://pinecast.com].

7. Juli 202625 min